Has Richard Madonna received payments from drug or device companies?

Yes. Drug and device makers reported $75,082 in general payments to Richard Madonna across 161 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Madonna did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Madonna come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Madonna

Optometrist · New York, NYNPI 1194798637

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 29.8% of the total. Among optometrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$75,082in general payments, 2019–2025

Across 161 payments — averaging $466.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bausch & Lomb Americas Inc.$22K
Aerie Pharmaceuticals, Inc.$21K
Carl Zeiss Meditec, Inc.$13K
AbbVie$10K
Alcon$4K
Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
plus $3K from 8 others

What the payments were for

Consulting fees$23,51531%
Speaking & faculty fees$39,55053%
Travel & lodging$6,4629%
Food & beverage$5,5557%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bausch & Lomb Americas Inc.	27	$22,346
Aerie Pharmaceuticals, Inc.	45	$21,242
Carl Zeiss Meditec, Inc.	24	$12,511
AbbVie(2 entities)	30	$9,736
Alcon	10	$3,675
Bausch & Lomb, A Division Of Bausch Health US, LLC	6	$2,225
Dompe US, Inc.	4	$1,649
Glaukos Corporation	3	$904
Topcon Healthcare, Inc.	3	$371
Eyevance Pharmaceuticals LLC	2	$185
Novartis	3	$119
Sanofi	2	$50
Sun Pharmaceutical Industries Inc.	1	$37
Quidel Corporation	1	$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$75,082 in reported general payments places this provider in the 95th percentile of 2,743 optometrist providers in New York.

See all optometrist providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VyzultaLatanoprostene Bunod	12	$3,608
LumiganBimatoprost	12	$3,384
Latanoprost	38	$638
Brimonidine Tartrate	11	$443

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Bausch & Lomb Americas Inc.Vyzulta	$22,346	$3,60812 claims
AbbVieLumigan	$9,736	$3,38412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,743 optometrist providers in New York.

Other optometrist in New York

Susan ResnickNew York$463K
Denise WhittamNew York$343K
Jennifer TsaiNew York$275K
Sophia VisanjiNew York$233K
Jason ComptonNew York$181K
George ZikosNew York$72K
Craig TischNew York$59K
Arthur JungNew York$50K
Milly MuiNew York$46K
Arkady SelenowNew York$28K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →